» Articles » PMID: 12234927

Dual Mode of Degradation of Cdc25 A Phosphatase

Overview
Journal EMBO J
Date 2002 Sep 18
PMID 12234927
Citations 86
Authors
Affiliations
Soon will be listed here.
Abstract

The Cdc25 dual-specificity phosphatases control progression through the eukaryotic cell division cycle by activating cyclin-dependent kinases. Cdc25 A regulates entry into S-phase by dephosphorylating Cdk2, it cooperates with activated oncogenes in inducing transformation and is overexpressed in several human tumors. DNA damage or DNA replication blocks induce phosphorylation of Cdc25 A and its subsequent degradation via the ubiquitin-proteasome pathway. Here we have investigated the regulation of Cdc25 A in the cell cycle. We found that Cdc25 A degradation during mitotic exit and in early G(1) is mediated by the anaphase-promoting complex or cyclosome (APC/C)(Cdh1) ligase, and that a KEN-box motif in the N-terminus of the protein is required for its targeted degradation. Interestingly, the KEN-box mutated protein remains unstable in interphase and upon ionizing radiation exposure. Moreover, SCF (Skp1/Cullin/F-box) inactivation using an interfering Cul1 mutant accumulates and stabilizes Cdc25 A. The presence of Cul1 and Skp1 in Cdc25 A immunocomplexes suggests a direct involvement of SCF in Cdc25 A degradation during interphase. We propose that a dual mechanism of regulated degradation allows for fine tuning of Cdc25 A abundance in response to cell environment.

Citing Articles

A perturbation approach for refining Boolean models of cell cycle regulation.

Banerjee A, Rahaman A, Mehandale A, Kraikivski P PLoS One. 2024; 19(9):e0306523.

PMID: 39240895 PMC: 11379194. DOI: 10.1371/journal.pone.0306523.


Potential of CDC25 phosphatases in cancer research and treatment: key to precision medicine.

Dakilah I, Harb A, Abu-Gharbieh E, El-Huneidi W, Taneera J, Hamoudi R Front Pharmacol. 2024; 15:1324001.

PMID: 38313315 PMC: 10834672. DOI: 10.3389/fphar.2024.1324001.


Cyclin A-CDK1 suppresses the expression of the CDK1 activator CDC25A to safeguard timely mitotic entry.

Ng L, Ma H, Poon R J Biol Chem. 2023; 299(3):102957.

PMID: 36717077 PMC: 9986519. DOI: 10.1016/j.jbc.2023.102957.


Upregulation of anaphase promoting complex (APC) 7 as a prognostic marker for esophageal squamous cell carcinoma: A hospital based study.

Ali E, Kalita M, Kalita S, Talukdar J, Deka A, Sultana J Heliyon. 2022; 8(6):e09722.

PMID: 35761933 PMC: 9233225. DOI: 10.1016/j.heliyon.2022.e09722.


The SCF Complex Is Essential to Maintain Genome and Chromosome Stability.

Thompson L, Rutherford K, Lepage C, McManus K Int J Mol Sci. 2021; 22(16).

PMID: 34445249 PMC: 8395177. DOI: 10.3390/ijms22168544.


References
1.
Krek W, Nigg E . Differential phosphorylation of vertebrate p34cdc2 kinase at the G1/S and G2/M transitions of the cell cycle: identification of major phosphorylation sites. EMBO J. 1991; 10(2):305-16. PMC: 452647. DOI: 10.1002/j.1460-2075.1991.tb07951.x. View

2.
Norbury C, Blow J, Nurse P . Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 1991; 10(11):3321-9. PMC: 453058. DOI: 10.1002/j.1460-2075.1991.tb04896.x. View

3.
Cenciarelli C, Chiaur D, Guardavaccaro D, Parks W, Vidal M, Pagano M . Identification of a family of human F-box proteins. Curr Biol. 1999; 9(20):1177-9. DOI: 10.1016/S0960-9822(00)80020-2. View

4.
Winston J, Koepp D, Zhu C, Elledge S, Harper J . A family of mammalian F-box proteins. Curr Biol. 1999; 9(20):1180-2. DOI: 10.1016/S0960-9822(00)80021-4. View

5.
Clute P, Pines J . Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol. 1999; 1(2):82-7. DOI: 10.1038/10049. View